Your browser doesn't support javascript.
loading
Integrated multiomic analysis reveals comprehensive tumour heterogeneity and novel immunophenotypic classification in hepatocellular carcinomas.
Zhang, Qi; Lou, Yu; Yang, Jiaqi; Wang, Junli; Feng, Jie; Zhao, Yali; Wang, Lin; Huang, Xing; Fu, Qihan; Ye, Mao; Zhang, Xiaozhen; Chen, Yiwen; Ma, Ce; Ge, Hongbin; Wang, Jianing; Wu, Jiangchao; Wei, Tao; Chen, Qi; Wu, Junqing; Yu, Chengxuan; Xiao, Yanyu; Feng, Xinhua; Guo, Guoji; Liang, Tingbo; Bai, Xueli.
Affiliation
  • Zhang Q; Department of Hepatobiliary and Pancreatic Surgery, The First Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou, China.
  • Lou Y; Zhejiang Provincial Key Laboratory of Pancreatic Disease, The First Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou, China.
  • Yang J; The Innovation Center for the Study of Pancreatic Diseases of Zhejiang Province, Hangzhou, China.
  • Wang J; Department of Hepatobiliary and Pancreatic Surgery, The First Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou, China.
  • Feng J; Zhejiang Provincial Key Laboratory of Pancreatic Disease, The First Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou, China.
  • Zhao Y; The Innovation Center for the Study of Pancreatic Diseases of Zhejiang Province, Hangzhou, China.
  • Wang L; Department of Hepatobiliary and Pancreatic Surgery, The First Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou, China.
  • Huang X; Zhejiang Provincial Key Laboratory of Pancreatic Disease, The First Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou, China.
  • Fu Q; The Innovation Center for the Study of Pancreatic Diseases of Zhejiang Province, Hangzhou, China.
  • Ye M; Department of Hepatobiliary and Pancreatic Surgery, The First Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou, China.
  • Zhang X; Zhejiang Provincial Key Laboratory of Pancreatic Disease, The First Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou, China.
  • Chen Y; The Innovation Center for the Study of Pancreatic Diseases of Zhejiang Province, Hangzhou, China.
  • Ma C; Beijing Neurosurgical Institute, Beijing Tiantan Hospital, Capital Medical University, Beijing, China.
  • Ge H; Novogene Biotechnology Inc, Beijing, China.
  • Wang J; Zhejiang Provincial Key Laboratory of Pancreatic Disease, The First Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou, China.
  • Wu J; Zhejiang Provincial Key Laboratory of Pancreatic Disease, The First Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou, China.
  • Wei T; Zhejiang Provincial Key Laboratory of Pancreatic Disease, The First Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou, China.
  • Chen Q; The Innovation Center for the Study of Pancreatic Diseases of Zhejiang Province, Hangzhou, China.
  • Wu J; Department of Medical Oncology, The First Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou, China.
  • Yu C; Department of Hepatobiliary and Pancreatic Surgery, The First Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou, China.
  • Xiao Y; Zhejiang Provincial Key Laboratory of Pancreatic Disease, The First Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou, China.
  • Feng X; The Innovation Center for the Study of Pancreatic Diseases of Zhejiang Province, Hangzhou, China.
  • Guo G; Department of Hepatobiliary and Pancreatic Surgery, The First Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou, China.
  • Liang T; Zhejiang Provincial Key Laboratory of Pancreatic Disease, The First Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou, China.
  • Bai X; The Innovation Center for the Study of Pancreatic Diseases of Zhejiang Province, Hangzhou, China.
Gut ; 68(11): 2019-2031, 2019 11.
Article in En | MEDLINE | ID: mdl-31227589

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Carcinoma, Hepatocellular / Liver Neoplasms Type of study: Prognostic_studies Limits: Humans Language: En Journal: Gut Year: 2019 Type: Article Affiliation country: China

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Carcinoma, Hepatocellular / Liver Neoplasms Type of study: Prognostic_studies Limits: Humans Language: En Journal: Gut Year: 2019 Type: Article Affiliation country: China